Co-Diagnostics Completes Principal Design of Monkeypox Virus Test
Co-Diagnostics completed the principal design work of a PCR test for the monkeypox virus, which is exhibiting a multi-country outbreak.
Read MorePosted by Andy Lundin | May 30, 2022 | Immunoassay Reagents & test Kits |
Co-Diagnostics completed the principal design work of a PCR test for the monkeypox virus, which is exhibiting a multi-country outbreak.
Read MorePosted by Andy Lundin | May 24, 2022 | Diagnostic Technologies |
Researchers developed a biosensor for improved diagnostics sensitivity using a method that generates nanostructured and nanoporous surfaces.
Read MorePosted by Andy Lundin | May 20, 2022 | Cancer |
Researchers identified cancer biomarkers based on a type of genetic modification that predicts the type of tumor immune environment and patient outcomes.
Read MorePosted by Andy Lundin | May 20, 2022 | Covid 19, Immunoassay Reagents & test Kits |
Next-generation point-of-care diagnostics company LumiraDx announced that its quick SARS-CoV-2 Ag Ultra Test achieved CE Marking.
Read MorePosted by Andy Lundin | May 12, 2022 | Computing Systems, Covid 19, Rapid Assays |
The Center of BioModular Multi-Scale Systems for Precision Medicine creates rapid tests for human ailments like cancer, stroke, and COVID.
Read More